201 Multicenter Randomized Trial of Everolimus vs. Mycophenolate Mofetil in Heart Transplantation: Final 24 Month Analysis of Efficacy and Safety

Journal article

Peer reviewed

J. Kobashigawa, D. Pauly, A. Kfoury, H. Ross, S.-S. Wang, B. Cantin, A. van Bakel, R.C. Starling, S. Hirt, G. Dong, …

The Journal of heart and lung transplantation, v 31(4), pp S75-S75

Apr 2012

Additional Links

5 Record Views

Title: 201 Multicenter Randomized Trial of Everolimus vs. Mycophenolate Mofetil in Heart Transplantation: Final 24 Month Analysis of Efficacy and Safety
Creators: J. Kobashigawa - Cedars-Sinai Heart Institute, Los Angeles
D. Pauly - University of Florida, College of Medicine, Gainesville
A. Kfoury - Intermountain Medical Center
H. Ross - University Health Network
S.-S. Wang - National Taiwan University
B. Cantin - Quebec Heart Institute, Quebec, Canada
A. van Bakel - Medical University of South Carolina
R.C. Starling - Cleveland Clinic
S. Hirt - University Hospital Regensburg
G. Dong - Novartis (Switzerland)
C. Panis - Novartis (Switzerland)
P. Lopez - Novartis (Switzerland)
H. Eisen - Hahnemann University Hospital
Publication Details: The Journal of heart and lung transplantation, v 31(4), pp S75-S75
Publisher: Elsevier
Resource Type: Journal article
Language: English
Web of Science ID: WOS:000302207900201
Other Identifier: 991019335321004721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Web of Science research areas: Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation